Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients

Journal of Patient-Reported Outcomes

Table 4 Correlation between QLQ-BN20 with resilience, depression and anxiety (construct validity)

QLQ-BN20	Resilience score	Depression score	Anxiety score
Future uncertainty	− 0.473 (< 0.001)*	0.614 (< 0.001)*	0.514 (< 0.001)*
Symptoms
Visual disorder	− 0.347 (< 0.001)*	0.277 (< 0.001)*	0.139 (0.029)*
Motor dysfunction	− 0.571 (< 0.001)*	0.458 (< 0.001)*	0.209 (0.001)*
Communication deficit	− 0.514 (< 0.001)*	0.425 (< 0.001)*	0.211 (0.001)*
Headache	− 0.121 (0.054)	0.236 (< 0.001)*	0.246 (< 0.001)*
Seizures	− 0.168 (0.008)*	0.149 (0.018)*	0.014 (0.822)
Drowsiness	− 0.408 (< 0.001)*	0.442 (< 0.001)*	0.262 (< 0.001)*
Hair loss	− 0.196 (0.002)*	0.144 (0.022)*	0.138 (0.029)*
Itchy skin	− 0.166 (0.008) *	0.185 (0.003)*	0.145 (0.022)*
Weakness in leg	− 0.478 (< 0.001)*	0.437 (< 0.001)*	0.284 (< 0.001)*
Bladder control	− 0.218 (0.001)*	0.277 (< 0.001)*	0.220 (< 0.001)*